May 16, 2019
”Over the past year, we’ve tripled the number of employees and I’m very pleased to see that our entire team is performing high quality work with great commitment. Xspray is today a company well-equipped to take a drug all the way to a finished product.”
Per Andersson, CEO Xspray Pharma AB (publ)
January–March 2019, Group
Because no Group existed during the same period in the previous year, there are no comparative figures.
• Net sales amounted to SEK 0 thousand
• Earnings before tax amounted to SEK -8,503 thousand
• Earnings per share before dilution